Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
mercaptopurine
i
Other names:
6-MP
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Generic mfg.
Drug class:
DNA synthesis inhibitor, PRPP amidotransferase inhibitor
Related drugs:
‹
cisplatin (330)
gemcitabine (181)
temozolomide (114)
cytarabine (99)
oxaliplatin (57)
dacarbazine (22)
cytarabine/daunorubicin liposomal formulation (19)
clofarabine (16)
carmustine (14)
mitomycin (10)
temozolomide gel (7)
nedaplatin (6)
fludarabine IV (6)
nelarabine (5)
bleomycin (4)
hydroxyurea (3)
thiotepa (3)
FF-10502 (2)
fotemustine (2)
streptozocin (2)
fludarabine oral (2)
thioguanine (2)
fosgemcitabine palabenamide (1)
asparagine cytarabine conjugate (1)
gemcitabine intravesical system (1)
mitomycin urothelial gel (1)
melphalan hepatic delivery system (1)
INT230-6 (1)
Ganfule (0)
liposomal cisplatin (0)
MKC-1106 (0)
miriplatin (0)
zinostatin (0)
pegylated liposomal mitomycin-c prodrug (0)
mercaptopurine oral suspension (0)
gemcitabine with RenovoCath (0)
cytarabine ocfosfate (0)
TG6002 (0)
dimesna (0)
mitomycin intravesicular (0)
SY-2101 (0)
captisol-enabled melphalan (0)
CO 1.01 (0)
D07001 (0)
TAS-118 (0)
PRV211 (0)
LP-100 (0)
PCS3117 (0)
PTX-200 (0)
cisplatin (330)
gemcitabine (181)
temozolomide (114)
cytarabine (99)
oxaliplatin (57)
dacarbazine (22)
cytarabine/daunorubicin liposomal formulation (19)
clofarabine (16)
carmustine (14)
mitomycin (10)
temozolomide gel (7)
nedaplatin (6)
fludarabine IV (6)
nelarabine (5)
bleomycin (4)
hydroxyurea (3)
thiotepa (3)
FF-10502 (2)
fotemustine (2)
streptozocin (2)
fludarabine oral (2)
thioguanine (2)
fosgemcitabine palabenamide (1)
asparagine cytarabine conjugate (1)
gemcitabine intravesical system (1)
mitomycin urothelial gel (1)
melphalan hepatic delivery system (1)
INT230-6 (1)
Ganfule (0)
liposomal cisplatin (0)
MKC-1106 (0)
miriplatin (0)
zinostatin (0)
pegylated liposomal mitomycin-c prodrug (0)
mercaptopurine oral suspension (0)
gemcitabine with RenovoCath (0)
cytarabine ocfosfate (0)
TG6002 (0)
dimesna (0)
mitomycin intravesicular (0)
SY-2101 (0)
captisol-enabled melphalan (0)
CO 1.01 (0)
D07001 (0)
TAS-118 (0)
PRV211 (0)
LP-100 (0)
PCS3117 (0)
PTX-200 (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Acute Lymphocytic Leukemia
No biomarker
Acute Lymphocytic Leukemia
mercaptopurine
Sensitive: A1 - Approval
mercaptopurine
Sensitive
:
A1
mercaptopurine
Sensitive: A1 - Approval
mercaptopurine
Sensitive
:
A1
NT5C2 mutation
Acute Lymphocytic Leukemia
NT5C2 mutation
Acute Lymphocytic Leukemia
mercaptopurine
Resistant: D – Preclinical
mercaptopurine
Resistant
:
D
mercaptopurine
Resistant: D – Preclinical
mercaptopurine
Resistant
:
D
NT5C2 R367Q
T Acute Lymphoblastic Leukemia
NT5C2 R367Q
T Acute Lymphoblastic Leukemia
mercaptopurine
Resistant: D – Preclinical
mercaptopurine
Resistant
:
D
mercaptopurine
Resistant: D – Preclinical
mercaptopurine
Resistant
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.